Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes

Charlotte Andersson, Stig Lyngbæk, Cu Dinh Nguyen, Mia Nielsen, Gunnar H Gislason, Lars Køber, Christian Torp-Pedersen

    45 Citationer (Scopus)

    Abstract

    Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes.
    OriginalsprogEngelsk
    TidsskriftJ A M A: The Journal of the American Medical Association
    Vol/bind308
    Udgave nummer9
    Sider (fra-til)882-9
    Antal sider8
    ISSN0098-7484
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes'. Sammen danner de et unikt fingeraftryk.

    Citationsformater